AMN director gets 8,304 RSUs, 8,325 shares

Jones Daphne E reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Jones Daphne E reported acquisition or exercise transactions in this Form 4 filing.

AMN Healthcare Services director Daphne E. Jones reported routine equity compensation activity. On May 1, 2026, 8,325 Restricted Stock Units (RSUs) vested and settled into 8,325 shares of AMN common stock, increasing her direct common stock holdings to 17,124 shares.

On the same date, she received a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan. Each RSU represents a right to receive one share of common stock and will vest on the earlier of the one-year anniversary of the grant or the company’s 2027 annual shareholder meeting, with settlement at her separation from service.

Insider Trade Summary

8,325 shares exercised/converted

Exercise 3 txns

Insider Jones Daphne E

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	8,325	$0.00	$0.00
Grant/Award	Restricted Stock Units	8,304	$0.00	$0.00
Exercise	Common Stock	8,325	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 8,304 contracts (Direct); Common Stock — 17,124 shares (Direct)

Footnotes (6)

F1. AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
F2. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
F3. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.
F4. RSUs do not have an expiration date.
F5. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
F6. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

Key Figures

RSUs vested to common stock: 8,325 shares Common shares held after transactions: 17,124 shares New RSU grant: 8,304 RSUs +2 more

5 metrics

RSUs vested to common stock 8,325 shares RSUs converted to AMN common stock on May 1, 2026

Common shares held after transactions 17,124 shares Direct AMN common stock ownership following Form 4 transactions

New RSU grant 8,304 RSUs Granted May 1, 2026 under AMN Healthcare 2025 Equity Plan

Underlying common for new RSUs 8,304 shares Each RSU represents the right to one AMN common share

RSU exercise/vest count 8,325 RSUs Derivative exercise/conversion count in transaction summary

Key Terms

Restricted Stock Units, AMN Healthcare 2017 Equity Plan, AMN Healthcare 2025 Equity Plan, vest on the earlier of, +1 more

5 terms

Restricted Stock Units financial

"AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AMN Healthcare 2017 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan."

AMN Healthcare 2025 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

vest on the earlier of financial

"RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary..."

separation from service financial

"RSUs identified in this row will settle on the date of the director's separation from service with the Company."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AMN (AMN) director Daphne E. Jones report?

Daphne E. Jones reported RSU-related equity compensation. 8,325 RSUs vested into 8,325 AMN common shares, and she received a new grant of 8,304 RSUs. These are compensation-related acquisitions rather than open-market stock purchases or sales.

How many AMN (AMN) shares does Daphne E. Jones hold after these transactions?

After these transactions, Daphne E. Jones directly holds 17,124 shares of AMN common stock. This reflects the settlement of 8,325 RSUs into common shares, adding to her prior holdings as reported in the Form 4 filing.

What are the key terms of the new 8,304 RSU grant to AMN (AMN) director Jones?

Jones received 8,304 RSUs under the AMN Healthcare 2025 Equity Plan. Each RSU represents one future AMN share and vests on the earlier of one year from the May 1, 2026 grant date or the 2027 annual shareholder meeting, then settles at her separation from service.

Were there any open-market stock sales or purchases by AMN (AMN) director Jones?

No open-market sales or purchases were reported. The Form 4 shows an RSU vesting that delivered 8,325 AMN common shares and a new 8,304 RSU grant, both categorized as acquisitions related to equity compensation, not market trades.

What AMN (AMN) equity plans are referenced in Daphne E. Jones’s Form 4 filing?

The filing references the AMN Healthcare 2017 Equity Plan for the vested RSUs and the AMN Healthcare 2025 Equity Plan for the new 8,304 RSU grant. Both plans grant RSUs that convert into AMN common stock upon vesting and settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/04/2026 - 04:36 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones Daphne E

(Last)

(First)

(Middle)

C/O AMN HEALTHCARE SERVICES, INC.

12400 HIGH BLUFF DRIVE, SUITE 500

(Street)

SAN DIEGO

CALIFORNIA

92130

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		M⁽¹⁾		8,325	A	$0	17,124	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	05/01/2026		M			8,325	⁽³⁾	⁽⁴⁾	Common Stock	8,325	$0	0	D
Restricted Stock Units	⁽⁵⁾	05/01/2026		A		8,304		⁽⁶⁾	⁽⁴⁾	Common Stock	8,304	$0	8,304	D

Explanation of Responses:

1. AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

2. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

3. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

4. RSUs do not have an expiration date.

5. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

6. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

Remarks:

	/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Daphne E. Jones	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR